Nitric oxide, salt sensitivity, and cardiorenal injury in hypertension

Seminars in Nephrology

Volumn 19, Issue 3, 1999, Pages 296-303

  Raij, Leopoldo ^a,b  

^a UNIVERSITY OF MINNESOTA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIN 1; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

BLOOD PRESSURE; CARDIOVASCULAR EFFECT; HUMAN; HYPERTENSION; INSULIN RESISTANCE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SALT INTAKE; URINARY EXCRETION;

ADAPTATION, PHYSIOLOGICAL; ALBUMINURIA; ANIMALS; BLOOD VESSELS; CARDIOVASCULAR DISEASES; ENDOTHELIUM, VASCULAR; HUMANS; HYPERTENSION; INSULIN RESISTANCE; NITRIC OXIDE; SODIUM CHLORIDE;

EID: 0032925960     PISSN: 02709295     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (58)

1. Weinberger MH: Effects of sodium on blood pressure in humans, in Laragh JH, Brenner BM (eds): Effects of sodium on blood pressure in humans of Book. New York, NY, Raven, 1995, pp 2703-2713
2. Campese VM: Salt sensitivity in hypertension. Renal and cardiovascular implications. Hypertension 23:531-550, 1994
3. Weinberger MH, Fineberg NS: Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension 18:67-71, 1991
4. Morimoto A, Uzu T, Fujii T, et al: Sodium sensitivity and cardiovascular events in patients with essential hypertension. Lancet 350:1734-1737, 1997
5. Grim CE, Henry JP, Myers H: High blood pressure in blacks: Salt, slavery, survival, stress, and racism, in Laragh JH, Brenner BM (eds): High blood pressure in blacks: Salt, slavery, survival, stress, and racism. New York, NY, Raven, 1995, pp 171-207
6. Cowley Jr AW, Roman RJ: The role of the kidney in hypertension. JAMA 275:1581-1589, 1996
7. Shulman NB, Ford CE, Hall WD, et al: Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: Results from the hypertension detection and follow-up program. The Hypertension Detection and Follow-up Program Cooperative Group. Hypertension 13:180-193, 1989
8. Parving HH: Microalbuminuria in essential hypertension and diabetes. J Hypertension 14:S89-S93, 1996
9. Whittle JC, Whelton PK, Seidler AJ, et al: Does racial variation in risk factors explain black-white differences in the incidence of hypertensive end-stage renal disease? Arch Intern Med 151:1359-1364, 1991
10. Raij L, Baylis C: Glomerular actions of nitric oxide. (Editorial Review). Kidney Int 48:20-32, 1995
11. Berk BC, Alexander RW: Biology of the vascular wall in hypertension, in Brenner BM (ed): Brenner & Rector's the Kidney, vol. 2 (ed 5). Philadelphia, PA, Saunders, 1996, pp 2049-2070
12. Haywood JR, Brennan TJ, Hinojosa C: Neurohumoral mechanisms of sodium-dependent hypertension. Fed Proc 44: 2393-2399, 1985
13. Taddei S, Virdis A, Mattel P, et al: Vasodilatation to acetylcholine in primary and secondary forms of human hypertension. Hypertension 21:929-933, 1993
14. Panza JA, Quyyumi AA, Brush JE, Jr, et al: Abnormal endothelial-dependent relaxation in patients with essential hypertension. N Engl J Med 323:22-27, 1990
15. Luscher TF, Raij L, Vanhoutte PM: Endothelium-dependent vascular responses in normotensive and hypertensive Dahl rats. Hypertension 9:157-63, 1987
16. Luscher TF, Vanhoutte PM: Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 8:344-348, 1986
17. Hayakawa H, Raij L: The link among nitric oxide synthase activity, endothelial function and aortic and ventricular hypertrophy in hypertension. Hypertension 29(part 2):235-241, 1997
18. Ribeiro MO, Antunes E, DeNucci G, et al: Chronic inhibition of nitric oxide synthesis: A new model of arterial hypertension. Hypertension 20:298-303, 1992
19. Tolins JP, Raij L: Comparison of converting enzyme inhibitor and calcium channel blocker in hypertensive glomerular injury. Hypertension 16:452-61, 1990
20. Vallance P, Collier J, Moncada S: Effect of endotheliumderived nitric oxide on peripheral arteriolar tone in man. Lancet 2:997-1000, 1989
21. Sessa WC, Pritchard K, Seyedi N, et al: Chronic exercise in dogs increases coronary vascular nitric oxide production and endothelial cell nitric oxide synthase gene expression. Circ Res 74:349-353, 1994
22. Awolesi MA, Sessa WC, Sumpio BE: Cyclic strain upregulates nitric oxide synthase in cultured bovine aortic endothelial cells. J Clin Invest 96:1449-1454, 1995
23. Dubey RK, Boegehold MA, Gillespie DG, et al: Increased nitric oxide activity in early renovascular hypertension. Am J Physiol 39:R118-124, 1996
24. Raij L: Nitric oxide in hypertension: Relationship with renal injury and left ventricular hypertrophy. Hypertension 31(part2):189-193, 1998
25. Tolins JP, Palmer RM, Moncada S, et al: Role of endothelium-derived relaxing factor in regulation of renal hemodynamic responses. Am J Physiol 258:H655-H662, 1990
26. Gibbons GH, Dau VJ: The emerging concept of vascular remodeling. N Engl J Med 330:1431-1438, 1994
27. Craven PA, Studer RK, Felder J, et al: Nitric oxide inhibition of transforming growth factor- and collagen synthesis in mesangial cells. Diabetes 46:671-681, 1997
28. Ketteler M, Noble NA, Border WA: Transforming growth factor-/3 and angiotensin II: The missing link from glomerular hyperfiltration to glomerulosclerosis? Annu Rev Physiol 57:279-295, 1995
29. Kannel WB: Blood pressure as a cardiovascular risk factor: Prevention and treatment. JAMA 275:1571-1576, 1996
30. Sventek P, Li J, Grove K, et al: Vascular structure and expression of endothelin-1 gene in L-NAME-treated spontaneously hypertensive rats. Hypertension 27:49-55, 1996
31. Takemoto M, Egashira K, Usui M, et al: Important role of tissue angiotensin-converting enzyme activity in the pathogenesis of coronary vascular and myocardial structural changes induced by long-term blockage of nitric oxide synthesis in rats. J Clin Invest 99:278-287, 1997
32. Bakris GL, Re RN: Endothelin modulates angiotensin II-induced mitogenesis of human mesangial cells. Am J Physiol 264(33):F937-F942, 1993
33. Garg UC, Hassid A: Nitric oxide-generating vasodilators and 8-bromo-cyclic guanosine monophosphate inhibit mitogenesis and proliferation of cultured rat vascular smooth muscle cells. J Clin Invest 83:1774-1777, 1989
34. Rudic RD, Shesely EG, Maeda N, et al: Direct evidence for the importance of endothelium-derived nitric oxide in vascular remodeling. J Clin Invest 101:731-736, 1998
35. Steudel W, Scherrer-Crosbie M, Bloch KD, et al: Sustained pulmonary hypertension and right ventricular hypertrophy after chronic hypoxia in mice with congenital deficiency of nitric oxide synthase 3. J Clin Invest 101:2468-2477, 1998
36. von der Leyen HE, Gibbons GH, Morishita R, et al: Gene therapy inhibiting neointimal vascular lesion: In vivo transfer of endothelial cell nitric oxide synthase gene. Proc Natl Acad Sei USA 92:1137-1141, 1995
37. Ichiki T, Usui M, Kato M, et al: Downregulation of angiotensin II type I receptor gene transcription by nitric oxide. Hypertension 31(l)(part 2):342-348, 1998
38. Boulanger C, Luscher TF: Release of endothelin from the porcine aorta. Inhibition by endothelium-derived nitric oxide. J Clin Invest 85(2):587-590, 1990
39. Griendling KK, Minieri CA, Ollerenshaw JD, et al: Angiotensin II stimulates NADH and NADPH oxidase activity in cultured vascular smooth muscle cells. Circ Res 74:11411148, 1994
40. Jaimes EA, Galceran JM, Raij L: Angiotensin II induces Superoxide anion production by mesangial cells. Kidney Int 54:775-784, 1998
41. phox mRNA expression and NADPH oxidase generation in rabbit aortic adventitial fibroblasts. Hypertension 32:331-337, 1998
42. Hayakawa H, Raij L: Nitric oxide synthase activity and renal injury in genetic hypertension. Hypertension 31 (part 2): 266-270, 1997
43. Hayakawa H, Coffee K, Raij L: Endothelial dysfunction and cardio-renal injury in experimental salt sensitive hypertension: Effects of antihypertensive therapy. Circulation 96:24072413, 1997
44. Nava E, Noll G, Luscher TF: Increased activity of constitutive nitric oxide synthase in cardiac endothelium in spontaneous hypertension. Circulation 91:2310-2313, 1995
45. Miyoshi A, Suzuki H, Fujiwara M, et al: Impairment of endothelial function in salt-sensitive hypertension in humans. Am J Hypertens 10:1083-1090, 1997
46. Zavaroni I, Bonora E, Pagliara M, et al: Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med 320:702-706, 1989
47. Steinberg HO, Brechtel G, Johnson A, et al: Insulinmediated skeletal muscle vasodilation is nitric oxide dependent. A novel action of insulin to increase nitric oxide release. J Clin Invest 94:1172-1179, 1994
48. Baron AD, Steinberg HO, Chaker H, et al: Insulinmediated skeletal muscle vasodilation contributes to both insulin sensitivity and responsiveness in lean humans. J Clin Invest 96:786-792, 1995
49. Bigazzi R, Bianchi S, Baldari D, et al: Microalbuminuria in salt-sensitive patients. A marker for renal and cardiovascular risk factors. Hypertension 23:195-9, 1994
50. Reaven GM, Twersky J, Chang H: Abnormalities of carbohydrates and lipid metabolism in Dahl rats. Hypertension 18:630-635, 1991
51. Mogensen CE, Christensen CK, Christensen NJ, et al: Renal protein handling in normal, hypertensive and diabetic man. Contrib Nephrol 24:139-152, 1981
52. Trevisan R, Bruttomesso D, Vedovato M: Enhanced responsiveness of blood pressure to sodium intake and to Angiotensin II is associated with insulin resistance in IDDM patients with microalbuminuria. Diabetes 47:1347-1352, 1998
53. Heimann JC, Drumond S, Alves ATR, et al: Left ventricular hypertrophy is more marked in salt-sensitive than in salt-resistant hypertensive patients. J Cardiovasc Pharmacol 17(suppl 2):S122-S124, 1991
54. London GM, Levenson JA, London AM, et al: Systemic compliance, renal hemodynamics, and sodium excretion in hypertension. Kidney Int 26:342-350, 1984
55. Cardillo C, Kilcoyne CM, Quyyumi AA, et al: Selective defect in nitric oxide synthesis may explain the impaired endothelium-dependent vasodilatation in patients with essential hypertension. Circulation 97:851-856, 1998
56. Taddei S, Virdis A, Mattel P, et al: Defective L-argininenitric oxide pathway in offspring of essential hypertensive patients. Circulation 1996:1298-1303, 1996
57. Majid DSA, Navar LG: Nitric Oxide in the mediation of pressure natriuresis. Clin Exp Pharmacol Physiol 24:595-599, 1997
58. Baron AD: Insulin and the vasculature-Old actors, new roles. J Investig Med 44:406-412, 1996